BerandaEXAS • BMV
add
Exact Sciences Ord Shs
Tutup sebelumnya
$1.812,04
Rentang tahun
$760,44 - $1.899,22
Kapitalisasi pasar
20,03Â M USD
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 878,38Â jt | 23,12% |
Biaya operasional | 697,33Â jt | 30,50% |
Penghasilan bersih | -85,96Â jt | 90,06% |
Margin laba bersih | -9,79 | 91,92% |
Penghasilan per saham | -0,21 | -250,00% |
EBITDA | -25,15Â jt | -321,14% |
Tarif pajak efektif | -1,02% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 964,71Â jt | -7,06% |
Total aset | 5,86Â M | -1,14% |
Total liabilitas | 3,46Â M | -1,88% |
Total ekuitas | 2,40 M | — |
Saham yang beredar | 190,89 jt | — |
Harga terhadap nilai buku | 144,04 | — |
Tingkat pengembalian aset | -3,46% | — |
Tingkat pengembalian modal | -4,09% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -85,96Â jt | 90,06% |
Kas dari operasi | 151,69Â jt | 222,31% |
Kas dari investasi | 91,12Â jt | 317,61% |
Kas dari pembiayaan | -75,87Â jt | -822,67% |
Perubahan kas bersih | 166,96Â jt | 1.294,93% |
Arus kas bebas | 74,97Â jt | 260,39% |
Tentang
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
In November 2025, Abbott Laboratories agreed to acquire Exact Sciences in a deal worth roughly $21 billion. Wikipedia
CEO
Didirikan
1 Jan 1995
Kantor pusat
Karyawan
7.150
